|1.||Zhang, Jie: 1 article (04/2007)|
|2.||Li, Shusheng: 1 article (04/2007)|
|3.||Wan, Lei: 1 article (04/2007)|
|4.||Wang, Guo-ping: 1 article (05/2004)|
|5.||Li, Shu-sheng: 1 article (05/2004)|
|6.||Wang, Hong-wei: 1 article (05/2004)|
05/01/2004 - "By observing the effect of API 0134, an active ingredient of green chiretta, on platelet membrane glycoprotein (GP) in patients with hyperlipemia to explore the mechanism of the anti-platelet aggregation effect of API. "
05/01/2004 - "[Effect of API 0134 on platelet membrane glycoprotein expression in patients with hyperlipemia]."
05/01/2004 - "The mean immunofluorescent intensity (MFI) of the platelet membrane glycoprotein GP II b/III a, GPIb, P-selectin (GMP-140) and von Willebrand's factor (vWF) in resting platelet, activated platelet (untreated or treated with API 0134 of different concentrations) were detected in 30 randomly selected patients with hyperlipemia, using immunofluorescent marker and flow cytometry. "
|2.||Membrane Glycoproteins (Membrane Glycoprotein)